1Suppliers
0Customers
3Debt Items
17Related Chains

Ovid Therapeutics Inc. Suppliers

TickerNameConfidenceEvidence
LGND Ligand Pharmaceuticals Incorporated 72% Reciprocal relationship from LGND graph: Reciprocal relationship from OVID graph: Reciprocal relationship from LGND graph: Reciprocal relationship from OVID graph: Reciprocal relationship from LGND g…

Ovid Therapeutics Inc. Customers

No clients on recordNo downstream customers found in our database for Ovid Therapeutics Inc..

Ovid Therapeutics Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
OVID-DEBT-11627 Xbrl Convertible 90% xbrl convertible detail from xbrl 2021-12-31.
OVID-DEBT-59802 Warrants outstanding: 1.09 90% xbrl warrant detail from xbrl 2026-03-31.
OVID-DEBT Debt stack $13.4M 90% Market cache reports total debt of $13.4M.

Ovid Therapeutics Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Ovid Therapeutics Inc..

Ovid Therapeutics Inc. Ownership

HolderNameConfidenceEvidence
OVID-OWNER-JANUS-HENDERSON-GROUP-PLC JANUS HENDERSON GROUP PLC 90% 13F overlay lists JANUS HENDERSON GROUP PLC as top holder; 104 tracked holders.

Ovid Therapeutics Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
SGMO Sangamo Therapeutics, Inc. 100.00 2
OBIO Orchestra BioMed Holdings, Inc. 100.00 2
CRMD CorMedix Inc. 100.00 2
AGEN Agenus Inc. 100.00 2
VKTX Viking Therapeutics, Inc. 100.00 2
ELUT Elutia Inc. 100.00 2
LONA LeonaBio, Inc. 100.00 2
PLX Protalix BioTherapeutics, Inc. 100.00 2
DNTH Dianthus Therapeutics, Inc. 50.00 2
OABIW OmniAb, Inc. 50.00 2
XOMA XOMA Royalty Corporation 50.00 2
XOMAP XOMA Royalty Corporation 50.00 2
LGND Ligand Pharmaceuticals Incorporated 38.88 1 ['supplier']
RYLAZE RYLAZE 23.09 2
LLY Eli Lilly and Company 14.78 2
SNYNF Sanofi 14.78 2
PVLA Palvella Therapeutics, Inc. 14.78 2